Cargando…
Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP
INTRODUCTION: As the COVID-19 pandemic progresses, rapidly emerging variants of concern raise fears that currently licensed vaccines may have reduced effectiveness against these new strains. In the municipality of Botucatu, São Paulo State, Brazil, a mass vaccination campaign using ChadOx1-nCoV19 wa...
Autores principales: | Costa Clemens, Sue Ann, Fortaleza, Carlos Magno Castelo Branco, Crowe, Madeleine, Tasca, Karen Ingrid, Spadaro, André Gasparini, Souza-Neto, Jayme Augusto, Grotto, Rejane Maria Tommasini, Sider, Regina, Jimeno, Jose, Verstraeten, Thomas, Clemens, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610568/ https://www.ncbi.nlm.nih.gov/pubmed/36311567 http://dx.doi.org/10.3389/fpubh.2022.1016402 |
Ejemplares similares
-
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil
por: Clemens, Sue Ann Costa, et al.
Publicado: (2022) -
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19
por: Badier, Laure, et al.
Publicado: (2021) -
Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome
por: Gillot, Constant, et al.
Publicado: (2022) -
Immunoglobulin A Vasculitis Following ChadOx1 nCoV-19/AZD1222 (AstraZeneca COVID-19 Vaccine) Vaccination
por: Seo, Hyun-Min, et al.
Publicado: (2023) -
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)